Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 6:3:73-82.
doi: 10.1016/j.dadm.2016.02.008. eCollection 2016.

Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS)

Danni Li  1 , Jeffrey R Misialek  2 , Eric Boerwinkle  3 , Rebecca F Gottesman  4 , A Richey Sharrett  5 , Thomas H Mosley  6 , Josef Coresh  5 , Lisa M Wruck  7 , David S Knopman  8 , Alvaro Alonso  2
Affiliations

Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS)

Danni Li et al. Alzheimers Dement (Amst). .

Abstract

Introduction: Phospholipids are altered in brains of patients with dementia and some studies suggest their plasma levels may be useful in the detection of mild cognitive impairment (MCI) and dementia.

Methods: We measured 188 plasma metabolites in participants who underwent a detailed neuropsychological assessment and classified as normal (n = 153), MCI (n = 145), or dementia (n = 143) by expert adjudication.

Results: Among 10 phospholipids recently implicated as altered in dementia, higher concentration of PC aa C36:6 was significantly associated with decreased prevalence of dementia (odds ratio = 0.71, 95% confidence interval = 0.50-1.00 per 1-SD increase). Adding these phospholipids to a model including multiple predictors of dementia led to only minimal improvement in detection (C statistic changed from 0.702 to 0.71).

Discussion: Some phospholipids and metabolites were altered in MCI and dementia but cross-sectional association was relatively weak and did not improve detection of MCI and dementia beyond information provided by clinical variables.

Keywords: AD; ARIC; ARIC-NCS; Alzheimer's disease; Dementia; MCI; Metabolites; Metabolomics; Mild cognitive impairment; Phospholipids; Plasma.

PubMed Disclaimer

References

    1. Klein J. Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J Neural Transm. 2000;107:1027–1063. - PubMed
    1. Pettegrew J.W., Panchalingam K., Hamilton R.L., McClure R.J. Brain membrane phospholipid alterations in Alzheimer's disease. Neurochem Res. 2001;26:771–782. - PubMed
    1. Grimm M.O., Grösgen S., Riemenschneider M., Tanila H., Grimm H.S., Hartmann T. From brain to food: Analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin–plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry. J Chromatogr A. 2011;1218:7713–7722. - PubMed
    1. Muldoon M.F., Ryan C.M., Sheu L., Yao J.K., Conklin S.M., Manuck S.B. Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood. J Nutr. 2010;140:848–853. - PMC - PubMed
    1. Beydoun M.A., Kaufman J.S., Satia J.A., Rosamond W., Folsom A.R. Plasma n−3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr. 2007;85:1103–1111. - PubMed